Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation

Neuron

Volumn 87, Issue 2, 2015, Pages 341-354

  Talbot, Sébastien ^a,b   Abdulnour, Raja Elie E ^c   Burkett, Patrick R ^b,c   Lee, Seungkyu ^a,b   Cronin, Shane J F ^a,d   Pascal, Maud A ^a,b,e   Laedermann, Cedric ^a,b   Foster, Simmie L ^a,b   Tran, Johnathan V ^a,b   Lai, Nicole ^a,b   Chiu, Isaac M ^a,b   Ghasemlou, Nader ^a,b   DiBiase, Matthew ^a,b   Roberson, David ^a,b   Von Hehn, Christian ^a,b   Agac, Busranour ^a,b   Haworth, Oliver ^c   Seki, Hiroyuki ^c   Penninger, Josef M ^d   Kuchroo, Vijay K ^b   Bean, Bruce P ^b   Levy, Bruce D ^c   Woolf, Clifford J ^a,b   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 5; LIDOCAINE ETHOBROMIDE; SODIUM CHANNEL NAV1.8; VASOACTIVE INTESTINAL POLYPEPTIDE; CAPSAICIN; CYTOKINE; FREUND ADJUVANT; GREEN FLUORESCENT PROTEIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; OVALBUMIN; QX-314;

ADAPTIVE IMMUNITY; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOCOMPETENT CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PAIN RECEPTOR; PRIORITY JOURNAL; PROTEIN SECRETION; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; AIRWAY REMODELING; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; NEWBORN; PHYSIOLOGY; RESPIRATORY TRACT ALLERGY; TIME;

AIRWAY REMODELING; ANESTHETICS, LOCAL; ANIMALS; ANIMALS, NEWBORN; CAPSAICIN; CYTOKINES; DISEASE MODELS, ANIMAL; FREUND'S ADJUVANT; GREEN FLUORESCENT PROTEINS; INTERLEUKIN-5; LIDOCAINE; MICE; NOCICEPTORS; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84937519445     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.06.007     Document Type: Article

References (67)

1. Akinbami L. Centers for Disease Control and Prevention National Center for Health Statistics. The state of childhood asthma, United States, 1980-2005. Adv. Data 2006, 1-24.
2. Ansel J.C., Brown J.R., Payan D.G., Brown M.A. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J.Immunol. 1993, 150:4478-4485.
3. Barnes P.J. Neuroeffector mechanisms: the interface between inflammation and neuronal responses. J.Allergy Clin. Immunol. 1996, 98:S73-S81.
4. Barnes P.J. New drugs for asthma. Nat. Rev. Drug Discov. 2004, 3:831-844.
5. Barnig C., Cernadas M., Dutile S., Liu X., Perrella M.A., Kazani S., Wechsler M.E., Israel E., Levy B.D. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med. 2013, 5:174ra26.
6. Bessac B.F., Jordt S.E. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda) 2008, 23:360-370.
7. Binshtok A.M., Bean B.P., Woolf C.J. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 2007, 449:607-610.
8. Binshtok A.M., Wang H., Zimmermann K., Amaya F., Vardeh D., Shi L., Brenner G.J., Ji R.R., Bean B.P., Woolf C.J., Samad T.A. Nociceptors are interleukin-1beta sensors. J.Neurosci. 2008, 28:14062-14073.
9. Bogaert P., Naessens T., De Koker S., Hennuy B., Hacha J., Smet M., Cataldo D., Di Valentin E., Piette J., Tournoy K.G., Grooten J. Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L679-L690.
10. Brenneis C., Kistner K., Puopolo M., Segal D., Roberson D., Sisignano M., Labocha S., Ferreirós N., Strominger A., Cobos E.J., et al. Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing. J.Neurosci. 2013, 33:315-326.
11. Caceres A.I., Brackmann M., Elia M.D., Bessac B.F., del Camino D., D'Amours M., Witek J.S., Fanger C.M., Chong J.A., Hayward N.J., et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc. Natl. Acad. Sci. USA 2009, 106:9099-9104.
12. Canning B.J., Spina D. Sensory nerves and airway irritability. Handb. Exp. Pharmacol. 2009, 139-183.
13. Canning B.J., Mori N., Mazzone S.B. Vagal afferent nerves regulating the cough reflex. Respir. Physiol. Neurobiol. 2006, 152:223-242.
14. Chiu I.M., von Hehn C.A., Woolf C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci. 2012, 15:1063-1067.
15. Chiu I.M., Heesters B.A., Ghasemlou N., Von Hehn C.A., Zhao F., Tran J., Wainger B., Strominger A., Muralidharan S., Horswill A.R., et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 2013, 501:52-57.
16. Delgado M., Leceta J., Sun W., Gomariz R.P., Ganea D. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Ann. NY Acad. Sci. 2000, 921:68-78.
17. Ding W., Stohl L.L., Wagner J.A., Granstein R.D. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J.Immunol. 2008, 181:6020-6026.
18. Engel M.A., Leffler A., Niedermirtl F., Babes A., Zimmermann K., Filipović M.R., Izydorczyk I., Eberhardt M., Kichko T.I., Mueller-Tribbensee S.M., et al. TRPA1 and substance P mediate colitis in mice. Gastroenterology 2011, 141:1346-1358.
19. Fanta C.H. Asthma. N.Engl. J. Med. 2009, 360:1002-1014.
20. Gauvreau G.M., O'Byrne P.M., Boulet L.P., Wang Y., Cockcroft D., Bigler J., FitzGerald J.M., Boedigheimer M., Davis B.E., Dias C., et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N.Engl. J. Med. 2014, 370:2102-2110.
21. Goetzl E.J., Voice J.K., Shen S., Dorsam G., Kong Y., West K.M., Morrison C.F., Harmar A.J. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc. Natl. Acad. Sci. USA 2001, 98:13854-13859.
22. Green R.H., Brightling C.E., Pavord I.D., Wardlaw A.J. Management of asthma in adults: current therapy and future directions. Postgrad. Med. J. 2003, 79:259-267.
23. Halim T.Y., Steer C.A., Mathä L., Gold M.J., Martinez-Gonzalez I., McNagny K.M., McKenzie A.N., Takei F. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014, 40:425-435.
24. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 1998, 50:265-270.
25. Haworth O., Cernadas M., Yang R., Serhan C.N., Levy B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 2008, 9:873-879.
26. Hosoi J., Murphy G.F., Egan C.L., Lerner E.A., Grabbe S., Asahina A., Granstein R.D. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993, 363:159-163.
27. Hox V., Vanoirbeek J.A., Alpizar Y.A., Voedisch S., Callebaut I., Bobic S., Sharify A., De Vooght V., Van Gerven L., Devos F., et al. Crucial role of transient receptor potential ankyrin 1 and mast cells in induction of nonallergic airway hyperreactivity in mice. Am. J. Respir. Crit. Care Med. 2013, 187:486-493.
28. Johnson J.R., Wiley R.E., Fattouh R., Swirski F.K., Gajewska B.U., Coyle A.J., Gutierrez-Ramos J.C., Ellis R., Inman M.D., Jordana M. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am. J. Respir. Crit. Care Med. 2004, 169:378-385.
29. Kanezaki M., Ebihara S., Gui P., Ebihara T., Kohzuki M. Effect of cigarette smoking on cough reflex induced by TRPV1 and TRPA1 stimulations. Respir. Med. 2012, 106:406-412.
30. Kradin R., MacLean J., Duckett S., Schneeberger E.E., Waeber C., Pinto C. Pulmonary response to inhaled antigen: neuroimmune interactions promote the recruitment of dendritic cells to the lung and the cellular immune response to inhaled antigen. Am. J. Pathol. 1997, 150:1735-1743.
31. Kumar V., Abbas A.K., Fausto N., Robbins S.L., Cotran R.S. Robbins and Cotran Pathologic Basis of Disease 2005, Elsevier Saunders, Philadelphia. Seventh Edition.
32. Kwong K., Carr M.J., Gibbard A., Savage T.J., Singh K., Jing J., Meeker S., Undem B.J. Voltage-gated sodium channels in nociceptive versus non-nociceptive nodose vagal sensory neurons innervating guinea pig lungs. J.Physiol. 2008, 586:1321-1336.
33. Lara-Marquez M., O'Dorisio M., O'Dorisio T., Shah M., Karacay B. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human Tcells. J.Immunol. 2001, 166:2522-2530.
34. Lennertz R.C., Kossyreva E.A., Smith A.K., Stucky C.L. TRPA1 mediates mechanical sensitization in nociceptors during inflammation. PLoS ONE 2012, 7:e43597.
35. Levine J.D., Clark R., Devor M., Helms C., Moskowitz M.A., Basbaum A.I. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984, 226:547-549.
36. Levy B.D., Vachier I., Serhan C.N. Resolution of inflammation in asthma. Clin. Chest Med. 2012, 33:559-570.
37. Licona-Limón P., Kim L.K., Palm N.W., Flavell R.A. TH2, allergy and group 2 innate lymphoid cells. Nat. Immunol. 2013, 14:536-542.
38. Lilly C.M., Bai T.R., Shore S.A., Hall A.E., Drazen J.M. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am. J. Respir. Crit. Care Med. 1995, 151:548-553.
39. Lindén A., Hansson L., Andersson A., Palmqvist M., Arvidsson P., Löfdahl C.G., Larsson P., Lötvall J. Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma. Thorax 2003, 58:217-221.
40. Liu X.J., Zhang Y., Liu T., Xu Z.Z., Park C.K., Berta T., Jiang D., Ji R.R. Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter. Cell Res. 2014, 24:1374-1377.
41. Locksley R.M. Asthma and allergic inflammation. Cell 2010, 140:777-783.
42. Mabalirajan U., Rehman R., Ahmad T., Kumar S., Singh S., Leishangthem G.D., Aich J., Kumar M., Khanna K., Singh V.P., et al. Linoleic acid metabolite drives severe asthma by causing airway epithelial injury. Sci. Rep. 2013, 3:1349.
43. Martinez F.D. Genes, environments, development and asthma: a reappraisal. Eur. Respir. J. 2007, 29:179-184.
44. Muroi Y., Undem B.J. Targeting voltage gated sodium channels NaV1.7, Na V1.8, and Na V1.9 for treatment of pathological cough. Lung 2014, 192:15-20.
45. Myers A.C., Kajekar R., Undem B.J. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L775-L781.
46. Ni D., Gu Q., Hu H.Z., Gao N., Zhu M.X., Lee L.Y. Thermal sensitivity of isolated vagal pulmonary sensory neurons: role of transient receptor potential vanilloid receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R541-R550.
47. Nussbaum J.C., Van Dyken S.J., von Moltke J., Cheng L.E., Mohapatra A., Molofsky A.B., Thornton E.E., Krummel M.F., Chawla A., Liang H.E., Locksley R.M. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013, 502:245-248.
48. Ortega H.G., Liu M.C., Pavord I.D., Brusselle G.G., FitzGerald J.M., Chetta A., Humbert M., Katz L.E., Keene O.N., Yancey S.W., Chanez P. MENSA Investigators. Mepolizumab treatment in patients with severe eosinophilic asthma. N.Engl. J. Med. 2014, 371:1198-1207.
49. Palmiter R.D., Behringer R.R., Quaife C.J., Maxwell F., Maxwell I.H., Brinster R.L. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987, 50:435-443.
50. Patterson R.N., Johnston B.T., Ardill J.E., Heaney L.G., McGarvey L.P. Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux. Thorax 2007, 62:491-495.
51. Ramsey C.D., Celedón J.C. The hygiene hypothesis and asthma. Curr. Opin. Pulm. Med. 2005, 11:14-20.
52. Rehman R., Bhat Y.A., Panda L., Mabalirajan U. TRPV1 inhibition attenuates IL-13 mediated asthma features in mice by reducing airway epithelial injury. Int. Immunopharmacol. 2013, 15:597-605.
53. Riol-Blanco L., Ordovas-Montanes J., Perro M., Naval E., Thiriot A., Alvarez D., Paust S., Wood J.N., von Andrian U.H. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 2014, 510:157-161.
54. Roberson D.P., Gudes S., Sprague J.M., Patoski H.A., Robson V.K., Blasl F., Duan B., Oh S.B., Bean B.P., Ma Q., et al. Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons. Nat. Neurosci. 2013, 16:910-918.
55. Saenz S.A., Siracusa M.C., Monticelli L.A., Ziegler C.G., Kim B.S., Brestoff J.R., Peterson L.W., Wherry E.J., Goldrath A.W., Bhandoola A., Artis D. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. J.Exp. Med. 2013, 210:1823-1837.
56. Serra M.F., Anjos-Valotta E.A., Olsen P.C., Couto G.C., Jurgilas P.B., Cotias A.C., Pão C.R., Ferreira T.P., Arantes A.C., Pires A.L., et al. Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. Anesthesiology 2012, 117:580-591.
57. Shi H.Z., Xiao C.Q., Zhong D., Qin S.M., Liu Y., Liang G.R., Xu H., Chen Y.Q., Long X.M., Xie Z.F. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am. J. Respir. Crit. Care Med. 1998, 157:204-209.
58. Stirling L.C., Forlani G., Baker M.D., Wood J.N., Matthews E.A., Dickenson A.H., Nassar M.A. Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice. Pain 2005, 113:27-36.
59. Su X., Camerer E., Hamilton J.R., Coughlin S.R., Matthay M.A. Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J.Immunol. 2005, 175:2598-2605.
60. Szallasi A., Cortright D.N., Blum C.A., Eid S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov. 2007, 6:357-372.
61. Tränkner D., Hahne N., Sugino K., Hoon M.A., Zuker C. Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways. Proc. Natl. Acad. Sci. USA 2014, 111:11515-11520.
62. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol. 2008, 8:169-182.
63. Voice J.K., Dorsam G., Lee H., Kong Y., Goetzl E.J. Allergic diathesis in transgenic mice with constitutive Tcell expression of inducible vasoactive intestinal peptide receptor. FASEB J. 2001, 15:2489-2496.
64. Walker J.A., Barlow J.L., McKenzie A.N. Innate lymphoid cells-how did we miss them?. Nat. Rev. Immunol. 2013, 13:75-87.
65. Weiss E.B., Patwardhan A.V. The response to lidocaine in bronchial asthma. Chest 1977, 72:429-438.
66. Wilhelm C., Hirota K., Stieglitz B., Van Snick J., Tolaini M., Lahl K., Sparwasser T., Helmby H., Stockinger B. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 2011, 12:1071-1077.
67. Wilson S.R., Thé L., Batia L.M., Beattie K., Katibah G.E., McClain S.P., Pellegrino M., Estandian D.M., Bautista D.M. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 2013, 155:285-295.